Genetic and Clinical Features in TP53-Mutated Patients With Myelodysplastic Neoplasms: A Retrospective Study Based on Next-Generation Sequencing Data.

Cancer Rep (Hoboken) · 2026 · PMC13239453 · PMID 42213496

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

showed a trendp = 0.079so close (0.05 < p ≤ 0.1)

Karyotypic analysis revealed a higher proportion of poor karyotypes in the multiple mutation subgroup ( p = 0.046), while cytogenetic risk stratification showed a trend toward more very poor risk in the multiple mutation group ( p = 0.079).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.